Skip to content

Study on the clinical mechanism of synergistic effect of Benefiting Qi for strengthening resistance and rt-PA intravenous injection in patients with acute ischemic stroke

Study on the clinical mechanism of synergistic effect of Benefiting Qi for strengthening resistance and rt-PA intravenous injection in patients with acute ischemic stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004068
Enrollment
Unknown
Registered
2020-11-21
Start date
2020-12-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

Sponsors

Dongfang Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for stroke in Chinese medicine and the diagnostic criteria for acute cerebral infarction in Western medicine; 2. Patients in accordance with TCM syndrome diagnosis and Qi deficiency syndrome; 3. Aged 18-90 years old, obtain informed consent of patients and family members; 4. Admission to the hospital within 6 hours of stroke symptoms and collect relevant clinical data; 5. The cranial MRI or CT did not clear the infarct area within 6 hours of the onset of stroke symptoms; 6. Patients who have not received anticoagulation therapy.

Exclusion criteria

Exclusion criteria: 1. Exclude diseases such as cerebral hemorrhage, intracranial infection, intracranial tumors, and moyamoya disease, vasculitis, carotid artery dissection and other diseases that may cause stenosis and occlusion of large blood vessels; 2. Patients who are mentally abnormal or unconscious and cannot cooperate with the examination and physical examination; 3. Failure to complete CTA+CTP or head MRI for various reasons, or the subject refuses to investigate and follow-up; 4. Serious diseases of heart, lung, liver, kidney and other organs; 5. Patients with coagulopathy.

Design outcomes

Primary

MeasureTime frame
NIHSS score;

Countries

China

Contacts

Public ContactLe Wang

Dongfang Hospital Beijing University of Chinese Medicine

13661172704@139.com+86 87611372

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026